logo

Intellia Therapeutics, Inc. (NTLA)



Trade NTLA now with
  Date
  Headline
5/3/2018 9:40:16 AM Wedbush Is Increasing Intellia Therapeutics, Inc. (NTLA) Q3 18 Estimate To -0.62 From -0.70
5/3/2018 9:40:00 AM Wedbush Is Increasing Intellia Therapeutics, Inc. (NTLA) Q2 18 Estimate To -0.59 From -0.67
5/1/2018 7:33:45 AM Intellia Therapeutics Posts Q1 Net Loss Of $21.36 Mln Or $0.51/share
3/15/2018 7:28:55 AM Wedbush Is Lowering Intellia Therapeutics, Inc. (NTLA) FY18 Rev. Estimate To 31.0 M From 42.0 M
3/15/2018 7:28:43 AM Wedbush Is Cutting Intellia Therapeutics, Inc. (NTLA) Q3 18 Rev. Estimate To 5.0 M From 16.0 M
3/15/2018 7:28:17 AM Wedbush Is Cutting Intellia Therapeutics, Inc. (NTLA) FY18 Estimate To -2.49 From -1.75
3/15/2018 7:27:35 AM Wedbush Is Cutting Intellia Therapeutics, Inc. (NTLA) Q4 18 Estimate To -0.48 From -0.33
3/15/2018 7:27:20 AM Wedbush Is Cutting Intellia Therapeutics, Inc. (NTLA) Q3 18 Estimate To -0.70 From -0.30
3/15/2018 7:26:52 AM Wedbush Is Cutting Intellia Therapeutics, Inc. (NTLA) Q2 18 Estimate To -0.67 From -0.57
3/15/2018 7:26:25 AM Wedbush Is Cutting Intellia Therapeutics, Inc. (NTLA) Q1 18 Estimate To -0.64 From -0.55
3/15/2018 7:25:55 AM Wedbush Reiterates Intellia Therapeutics, Inc. (NTLA) At Outperform With $36 Price Target
3/14/2018 7:34:55 AM Intellia Therapeutics Q4 Net Loss $24.0 Mln Vs Loss $10.6 Mln Last Year
11/1/2017 7:57:39 AM Wedbush Is Lowering Intellia Therapeutics, Inc. (NTLA) 2018 Estimate To -1.75 From -1.72
11/1/2017 7:57:23 AM Wedbush Is Increasing Intellia Therapeutics, Inc. (NTLA) 2017 Estimate To -1.72 From -1.76
9/27/2017 10:15:49 AM Wedbush Reiterates Intellia Therapeutics, Inc. (NTLA) At Ourperform With $29 Up From $25 Price Target
5/15/2017 6:55:28 PM Wedbush Reiterates Intellia Therapeutics, Inc. (NTLA) At Outperform With $25 Price Target
5/3/2017 9:07:22 AM Wedbush Reiterates Intellia Therapeutics, Inc. (NTLA) At Outperform With $25 Price Target
5/3/2017 9:06:53 AM Wedbush Is Cutting Intellia Therapeutics, Inc. (NTLA) 2018 Estimate To -1.45 From -1.24
5/3/2017 9:06:39 AM Wedbush Is Lowering Intellia Therapeutics, Inc. (NTLA) 2017 Estimate To -1.61 From -1.48